Previous Page  15 / 38 Next Page
Information
Show Menu
Previous Page 15 / 38 Next Page
Page Background

Nosov DA, et al. J Clin Oncol 2012

Antitumor activity of Tivozanib (AV-951):

phase II randomized discontinuation trial in mRCC